TY - JOUR
AU1 - Rossi, Roberta
AU2 - Burroughs, Andrew
AU3 - Caplin, Martyn
AB - LT might be considered in carefully selected patients. The risk of tumor recurrence remains a significant clinical problem after LT, but data focused on immunosuppression issue are lacking, and there are no currently approved strategies for prevention of recurrence or follow-up protocols. Further studies are needed to define universally accepted inclusion criteria, reliable predictors of better outcome, and optimal timing for LT.
TI - Liver Transplantation for Unresectable Neuroendocrine Tumor Liver Metastases
JF - Annals of Surgical Oncology
DO - 10.1245/s10434-014-3523-y
DA - 2014-02-22
UR - https://www.deepdyve.com/lp/springer-journals/liver-transplantation-for-unresectable-neuroendocrine-tumor-liver-JH4TMgjrDD
SP - 2398
EP - 2405
VL - 21
IS - 7
DP - DeepDyve
ER -